CONDENSED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 3,563	$ 859	$ 6,378	$ 1,633
General and administrative	1,506	362	3,434	843
Total operating expenses	5,069	1,221	9,812	2,476
Loss from operations	(5,069)	(1,221)	(9,812)	(2,476)
Other income (expense):
Interest income	98	0	238	0
Interest expense	0	(222)	0	(304)
Loss on debt extinguishment	0	(2,262)	0	(2,262)
Other income	0	4	0	5
Net loss	(4,971)	(3,701)	(9,574)	(5,037)
Preferred stock deemed dividend	0	(1,324)	0	(1,324)
Net loss attributable to common stockholders	$ (4,971)	$ (5,025)	$ (9,574)	$ (6,361)
Loss per share, basic (in dollars per share)	$ (0.36)	$ (1.43)	$ (0.70)	$ (1.84)
Loss per share, diluted (in dollars per share)	$ (0.36)	$ (1.43)	$ (0.70)	$ (1.84)
Weighted average number of shares of common stock, basic (in shares)	13,712,152	3,516,579	13,710,819	3,463,635
Weighted average number of shares of common stock, diluted (in shares)	13,712,152	3,516,579	13,710,819	3,463,635

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.